Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05423860 · ClinicalTrials.gov registry record
Phase I Human Analytics (HALO) Study
A clinical trial of Cancer and Cardiovascular Diseases, sponsored by HALO Diagnostics.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT05423860 is a study of Cancer and Cardiovascular Diseases that is actively recruiting participants, run by HALO Diagnostics. The registered enrollment target is 2,000 participants, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05423860, a study of Cancer and Cardiovascular Diseases, is actively recruiting participants, sponsored by HALO Diagnostics.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Discover, optimize, standardize, and validate clinical-trial measures and biomarkers used to diagnose and differentiate cardiovascular, oncologic, neurologic, and other diseases and disorders. Specifically, our research study endeavors to improve disease and disorder diagnosis to the earliest clinical states, in preclinical states, and to develop ensemble multivariate biomarker risk scores leading to cardiovascular, oncologic, neurologic, and other diseases and disorders. Additionally, the study aims to: * Evaluate data analysis techniques to improve diagnostic accuracy and reduce time to diagnosis. * Evaluate data analysis techniques to improve risk stratification for participants through machine learning algorithms. * Direct participants to relevant and applicable clinical trials.
Conditions Studied
Interventions
- OTHER no interventions will be performed (observational)
Study Locations (1)
California
- Desert Medical Imaging - Indian Wells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2022-03-16 |
| Est. Completion | 2037-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05423860
The ClinicalTrials.gov registry entry for NCT05423860 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (43% lower). The listed sponsor is HALO Diagnostics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which no interventions will be performed (observational) is the first listed.
NCT05423860 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05423860 about?
NCT05423860 is a clinical study titled "Phase I Human Analytics (HALO) Study". Discover, optimize, standardize, and validate clinical-trial measures and biomarkers used to diagnose and differentiate cardiovascular, oncologic, neurologic, and other diseases and disorders. Specifically, our research study endeavors to improve disease and disorder diagnosis to the earliest clinic...
What is the current status of trial NCT05423860?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2022-03-16. Estimated completion is 2037-03.
What conditions does trial NCT05423860 study?
This clinical trial studies the following conditions: Cancer, Cardiovascular Diseases, Dementia, Traumatic Brain Injury.
What interventions are being tested in trial NCT05423860?
The interventions under investigation include: no interventions will be performed (observational) (OTHER).
Who is sponsoring clinical trial NCT05423860?
This trial is sponsored by HALO Diagnostics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05423860 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.